0 results for 'Williams & Connolly LLP'
DLA Piper Practice Leader Starts Commercial Litigation Shop
Patrick Smith, co-chair of DLA Piper's white-collar and investigations group, has formed a new firm in New York called Smith Villazor with Rodney Villazor, a fellow former federal prosecutor who joined the global legal giant's litigation group last year.April Supreme Court Arguments: Last But Not Least
The final argument cycle of the current U.S. Supreme Court term will begin and end with a bang, with a roster of veteran advocates traipsing to the lectern in between.More Than 100 Viagra Suits Alleging Skin Cancer Headed to San Francisco
Lawsuits filed against Pfizer Inc. claiming that Viagra caused men to get skin cancer have been transferred to a judge in San Francisco by a federal judicial panel.Cahill Gordon, BASF Can't Escape Asbestos Fraud Suit
A federal judge in Newark has denied a motion by New York-based Cahill, Gordon & Reindel and two of its attorneys seeking to be dismissed from a putative class action suit claiming they conspired with a client to destroy and fabricate evidence in thousands of asbestos injury cases. The judge also denied motions to dismiss Cahill Gordon's alleged accomplice in the fraud, BASF Catalysts, along with two former in-house lawyers for the company.Baker & McKenzie, Yahoo Dodge Suit Alleging $2.7 Billion Bribery Scheme
Ideas Interactivas, a Mexican phone book publisher, had accused Yahoo and its lawyers of bribing a judge to escape a massive court judgment.City of Spokane v. United Nat. Ins.Co.
Click Here for FC&S Legal Expert Analysis City of Spokanev.United Nat. Ins. Co.KeyCite Yellow Flag - Negative TreatmentDistinguished by Mellin…Wiley Rein's FDA Head Joins DLA Piper, Plus More Lateral Moves
Wiley Rein's food and drug leader decamps for DLA Piper; Mayer Brown recruits a key Verizon in-house lawyer; Skadden hires from a high-profile boutique; and other notable additions from throughout The Am Law 200.Jury Hands Merck $200 Million in Fight With Gilead
The sizeable verdict is a fraction of Merck's demand in a feud over patents for the treatment of hepatitis C.Merck Wins Patent Battle Over Hepatitis C Drugs
As the case moves on to a damages phase, lawyers for Merck & Co. Inc. will push for a 10 percent cut of sales on Gilead Sciences Inc.'s blockbuster drug sofosbuvir.Katten Litigation Co-Leader Decamps, Plus More Lateral Moves
The U.S. Department of Commerce adds a high-profile partner from Katten Muchin Rosenman; Greenberg Traurig and Holland & Knight trade hires; Winston & Strawn's arbitration co-chair departs; and other notable additions from around The Am Law 200.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
The Essential Guide to Governance, Risk, and Compliance
Brought to you by Diligent Corporation
Download Now
2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates
Brought to you by LexisNexis® CounselLink®
Download Now
AI in Private Equity: A Guide for Gaining an Early Advantage
Brought to you by Ontra
Download Now
Why Are So Many Law Firms Suddenly Embracing Digital Transformation?
Brought to you by AllRize
Download Now